Aplastic anemia, an unusual hematologic disease, is the paradigm of the human bone
marrow failure syndromes. Almost universally fatal just a few decades ago, aplastic anemia …

Evidence has accumulated in the recent years further corroborating an immune-mediated
process underlying aplastic anemia pathogenesis. Hematopoietic stem-cell transplantation …

Aplastic anaemia is a rare haemopoietic stem-cell disorder that results in pancytopenia and
hypocellular bone marrow. Although most cases are acquired, there are unusual inherited …

Opinion statement Acquired aplastic anemia (AA) is a rare, life-threatening bone marrow
failure (BMF) disorder that affects patients of all ages and is caused by lymphocyte …

Aplastic anaemia is a rare, previously fatal condition with a significantly improved survival
rate owing to advances in understanding of the pathophysiology and improved treatment …

Acquired aplastic anemia (AA) in childhood remains an uncommon, life-threatening
disorder. Because of major advances in diagnosis and therapeutic approaches, AA in …

Acquired aplastic anemia (AA) is a rare heterogeneous disease characterized by
pancytopenia and hypoplastic bone marrow. The incidence is 2–3/million inhabitants/year …

The current outlook for a child with severe idiopathic aplastic anaemia (AA) is very much
better than in previous decades. In part, this may reflect better differentiation of idiopathic …

There is no standard or widely effective treatment of patients with moderate aplastic anemia
(MAA) or hypo-productive uni-lineage cytopenias (UC). Eltrombopag (EPAG), a small …

Aplastic anemia (AA) and hypoplastic myelodysplastic syndromes (hMDS) are often difficult
to distinguish. However, an accurate diagnosis is important because the prognosis and …